@entity356 is a @entity5 which has generally a very bad prognosis. The frequency of occurence of this disease in the population is dependent on the age and localisation. Most frequently, this disease has occured in Japan, China, countries of South Africa and Eastern Europe for a long time but @entity1 are more likely to suffer from this disease than @entity1 witha ratio of 2 : 1. METHODS: We retrospectively evaluated the group of @entity1 who had been treated in our complex oncology center in the course of five years RESULTS: We treated 572 @entity1 with @entity356 in five years period. 218 @entity1 of the total number were admitted, 185 @entity1 of all hospitalized @entity1 were operated (85 %). 53 @entity1 of our group of hospitalized @entity1 underwent adjuvant oncology therapy (24 %). Overall, five-year survival was 18.4 % in our group, the median survival time was 12.9 months. CONCLUSION: Radical surgery is considered to be the only treatment modality which can lead to @entity1  s cure under optimal conditions. Complex care for @entity1 with @entity356 should be centralized in big centers. Personalized oncological treatment should be a way how to get better results (Tab. 2, Fig. 5, Ref. 14).

Surgical treatment of XXXX .

@entity5 :: ('MESH:D009369', 'Disease') :: ['malignant disease'] @entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient', 'men'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer', 'gastric carcinoma', 'Gastric cancer']
@entity356 :: (MESH:D013274,Disease) :: ['gastric cancer']
